Jubilant Ingrevia Q1 Results Live : Jubilant Ingrevia declared their Q1 results on 16 Jul, 2024, revealing a 4.71% decrease in revenue and a 15.37% decrease in profit compared to the same period last year.
The company experienced a 4.66% decline in revenue but a significant 66.63% increase in profit when compared to the previous quarter.
Selling, general & administrative expenses saw a 7.81% increase quarter-on-quarter but a 13.22% decrease year-on-year.
Operating income showed a positive trend with a 27.25% increase quarter-on-quarter, although it decreased by 16.24% year-on-year.
The earnings per share (EPS) for Q1 stood at ₹3.08, marking a 15.15% decrease year-on-year.
Jubilant Ingrevia’s recent returns include -0.52% in the last 1 week, 21.82% in the last 6 months, and 15.41% year-to-date.
The company currently boasts a market capitalization of ₹9273.4 Cr with a 52-week high/low of ₹617 & ₹399 respectively.
Analysts covering Jubilant Ingrevia have varied ratings, with 1 analyst suggesting a Hold rating, 1 analyst recommending Buy, and 1 analyst advocating for Strong Buy.
As of 18 Jul, 2024, the consensus recommendation for Jubilant Ingrevia was to Buy.
Jubilant Ingrevia Financials
| Period | Q1 | Q4 | Q-o-Q Growth | Q1 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 1024.34 | 1074.44 | -4.66% | 1075.02 | -4.71% |
| Selling/ General/ Admin Expenses Total | 219.41 | 203.52 | +7.81% | 252.83 | -13.22% |
| Depreciation/ Amortization | 38.88 | 35.72 | +8.85% | 32.3 | +20.37% |
| Total Operating Expense | 953.69 | 1018.92 | -6.4% | 990.67 | -3.73% |
| Operating Income | 70.65 | 55.52 | +27.25% | 84.35 | -16.24% |
| Net Income Before Taxes | 66.03 | 51.35 | +28.59% | 81.31 | -18.79% |
| Net Income | 48.74 | 29.25 | +66.63% | 57.59 | -15.37% |
| Diluted Normalized EPS | 3.08 | 1.85 | +66.49% | 3.63 | -15.15% |
